Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer 07/22/2010 INTERVENTIONAL unchanged 5,879.85 0 Predictive Assays In Cervix Cancer 08/13/2010 INTERVENTIONAL unchanged 5,857.85 0 Rehabilitation of Cognitive Changes in Breast Cancer Survivors 08/16/2010 INTERVENTIONAL unchanged 5,854.85 0 Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors 09/09/2010 INTERVENTIONAL unchanged 5,830.85 0 Relaxation for Women With Breast Cancer Undergoing Radiotherapy 09/16/2010 INTERVENTIONAL unchanged 5,823.85 0 Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer 09/16/2010 INTERVENTIONAL unchanged 5,823.85 0 Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer 10/29/2010 INTERVENTIONAL unchanged 5,780.85 0 Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer 11/19/2010 INTERVENTIONAL unchanged 5,759.85 0 Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer 11/22/2010 INTERVENTIONAL unchanged 5,756.85 0 National Pregnancy Registry for Psychiatric Medications 11/23/2010 OBSERVATIONAL unchanged 5,755.85 0 Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer 11/24/2010 INTERVENTIONAL unchanged 5,754.85 0 Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer 12/24/2010 INTERVENTIONAL unchanged 5,724.85 0 Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer 01/07/2011 INTERVENTIONAL unchanged 5,710.85 0 Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT 01/13/2011 OBSERVATIONAL unchanged 5,704.85 0 Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer 02/02/2011 INTERVENTIONAL unchanged 5,684.85 0 ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis 02/23/2011 OBSERVATIONAL unchanged 5,663.85 0 Partial Breast Proton Therapy for Early Stage Breast Cancer 03/08/2011 INTERVENTIONAL unchanged 5,650.85 0 Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer 04/04/2011 INTERVENTIONAL unchanged 5,623.85 0 Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer 04/12/2011 INTERVENTIONAL unchanged 5,615.85 0 Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery 05/06/2011 INTERVENTIONAL unchanged 5,591.85 0 Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up 05/23/2011 INTERVENTIONAL unchanged 5,574.85 0 Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment 06/20/2011 INTERVENTIONAL unchanged 5,546.85 0 Cryopreservation of Ovarian Cortex in Girls With Turner Syndrome 08/04/2011 INTERVENTIONAL unchanged 5,501.85 0 Vitamin D and Physical Activity on Bone Health 08/18/2011 INTERVENTIONAL unchanged 5,487.85 0 Ovarian Reserve Testing in Female Young Adult Cancer Survivors 08/22/2011 INTERVENTIONAL unchanged 5,483.85 0 Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy 09/07/2011 OBSERVATIONAL unchanged 5,467.85 0 Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer 09/23/2011 INTERVENTIONAL unchanged 5,451.85 0 Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors 10/12/2011 INTERVENTIONAL unchanged 5,432.85 0 The Young Women's Breast Cancer Study 11/09/2011 OBSERVATIONAL unchanged 5,404.85 0 The Immune System's Response to Young Women's Breast Cancer 01/02/2012 OBSERVATIONAL unchanged 5,350.85 0 Part II: Exercise in Hispanic Breast Cancer Survivors 01/05/2012 INTERVENTIONAL unchanged 5,347.85 0 Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm 01/18/2012 INTERVENTIONAL unchanged 5,334.85 0 The Preoperative Health & Body Study 01/24/2012 INTERVENTIONAL unchanged 5,328.85 0 Prospective Screening for Breast Cancer-related Lymphedema 01/31/2012 OBSERVATIONAL unchanged 5,321.85 0 Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer 02/03/2012 INTERVENTIONAL unchanged 5,318.85 0 Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients 02/09/2012 INTERVENTIONAL unchanged 5,312.85 0 Cryopreservation of Ovarian Tissue 03/20/2012 INTERVENTIONAL unchanged 5,272.85 0 Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer 03/29/2012 INTERVENTIONAL unchanged 5,263.85 0 Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery 04/04/2012 INTERVENTIONAL unchanged 5,257.85 0 Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer 04/18/2012 INTERVENTIONAL unchanged 5,243.85 0 Radical Fimbriectomy for Young BRCA Mutation Carriers 05/30/2012 INTERVENTIONAL unchanged 5,201.85 0 Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development 06/20/2012 OBSERVATIONAL unchanged 5,180.85 0 Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System® 07/19/2012 INTERVENTIONAL unchanged 5,151.85 0 High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer 07/20/2012 INTERVENTIONAL unchanged 5,150.85 0 Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria 08/08/2012 INTERVENTIONAL unchanged 5,131.85 0 Improving the Treatment for Women With Early Stage Cancer of the Uterus 09/17/2012 INTERVENTIONAL unchanged 5,091.85 0 Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) 10/02/2012 INTERVENTIONAL unchanged 5,076.85 0 Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node 10/30/2012 INTERVENTIONAL unchanged 5,048.85 0 PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer 11/08/2012 INTERVENTIONAL unchanged 5,039.85 0 The Collection and Storage of Umbilical Cord Blood for Transplantation 11/20/2012 OBSERVATIONAL unchanged 5,027.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology